Exomnis is committed to translating science into clinical applications. Our technology is currently being tested in laboratory settings to engineer and optimise the ultimate therapeutic prototype. We want to make sure that our products meet all regulatory approvals and are tested in clinical settings. For that reason, our therapy is not available yet to any patients who are current sufferers.  

Opening of any clinical studies will be announced on our website.  

Exomnis practices Responsible Research and Innovation (RRI) principles. We endeavour to engage with our society during the research and innovation process, in order to inform, listen to and manage needs and expectations of our communities.